查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1448481

再生医学市场：趋势、预测、竞争分析

Regenerative Medicine Market: Trends, Forecast and Competitive Analysis
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

再生医学市场趋势及预测

预计到 2030 年，全球再生医学市场将达到 102 亿美元，2024 年至 2030 年复合年增长率预计为 3.0%。该市场的关键驱动因素是人们对个人化医疗的日益偏好、政府和私人机构对研发活动的投资增加以及干细胞治疗的技术进步。全球再生医学市场的未来前景广阔，在肌肉骨骼疾病、伤口护理、肿瘤学、眼科疾病和糖尿病领域都有机会。

再生医学市场新趋势

对产业动态产生直接影响的新兴趋势包括更多地采用干细胞技术以及更多地在组织工程和再生医学中使用 3D 生物列印技术。

在这个市场中，基于细胞的免疫和细胞疗法是最大的再生医学产品，肌肉骨骼疾病是最大的应用领域。再生医学市场各细分领域的成长情况如下图所示：

本研究按材料、产品、应用、分销管道和地区总结了全球再生医学市场的趋势和预测如下：

依材料分类[2018-2030年金额（百万美元）出货量分析]：

  • 合成
    • 鹰架材料
    • 人工血管移植材料
    • 水凝胶材料
  • 生物来源材料
    • 胶原蛋白
    • 不同材料
  • 基因改造材料
    • 去氧核糖核酸转染载体
    • 基因工程细胞
    • 3D聚合物技术
    • 基因改造的
    • 纤维母细胞
    • 神经干细胞
    • 基因活化矩阵
  • 药品
    • 小分子药物
    • 生技药品

依产品[2018-2030年金额（百万美元）出货量分析]：

  • 基于细胞的免疫治疗/细胞治疗产品
  • 组织工程产品
  • 小分子/生技药品
  • 基因治疗产品

依应用分【2018年至2030年出货收益分析（百万美元）】：肌肉骨骼疾病

  • 肌肉骨骼疾病
  • 伤口护理
  • 肿瘤学
  • 眼科疾病
  • 糖尿病
  • 其他的

依分销管道划分[2018-2030年金额（百万美元）出货量分析]

  • 医院
  • 诊所
  • 其他的

依地区划分【2018-2030年出货收益分析（百万美元）】：北美

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
  • 亚太地区
    • 中国
    • 印度
    • 日本
  • 其他的
    • 巴西

再生医学市场洞察

  • Lucintel 预计，由于政府加强对细胞治疗产品研发活动的支持，以及 FDA 颁布《治癒法案》以核准再生医学审批，基于细胞的免疫学和细胞治疗产品将成为预测期内最大的细分市场。预计这种情况将持续下去。
  • 在这个市场中，由于整形外科疾病的增加和老年人口的增长，预计肌肉骨骼疾病在预测期内仍将是最大的应用领域。
  • 由于先进技术的存在以及大量研究机构参与开发新疗法，预计北美在预测期内仍将是最大的地区。

常问问题

Q1.市场规模为：

答：预计到2030年，全球再生医学市场将达到102亿美元。

Q2.市场成长预测是多少：

答：2024年至2030年，再生医学市场预计复合年增长率为3.0%。

Q3.影响市场成长的关键驱动因素是：

A1. 该市场的关键驱动因素是人们对个人化医疗的日益偏好、政府和私人机构对研发活动的投资增加以及干细胞治疗的技术进步。

Q4.再生医学的主要最终用途是什么？

答：医院和诊所是再生医学的主要最终用途。

Q5.再生医学市场有哪些新趋势？

答：对产业动态有直接影响的新兴趋势包括干细胞技术的更多采用以及组织工程和再生医学中 3D 生物列印技术的更多使用。

Q6. 主要的再生医学公司有哪些？

答：主要的再生医学公司有：

  • Kite Pharma
  • Novartis
  • Vericel
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker
  • Spark Therapeutics
  • Zimmer Biomet

Q7. 未来再生医学原料领域哪个领域成长最快？

A4.Lucintel 预计，由于政府加强对细胞治疗产品相关研发活动的支持，以及 FDA 简化再生医学核准的治癒法案的颁布，基于细胞的免疫和细胞治疗产品将在预期期间继续增长。仍然是世界上最大的细分市场。

Q8：未来五年哪个地区的再生医学市场最大？

答：未来五年，北美仍将是最大的。

Q9. 可以客製化报告吗？

答：是的，Lucintel 列出了 10% 的客製化服务，无需额外费用。

目录

第二章 市场背景及分类

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势和预测
  • 全球再生医学市场趋势及预测
  • 按材料分類的全球再生医学市场
    • 合成
      • 鹰架
      • 人造血管材料
      • 水凝胶材料
    • 生物来源材料
      • 胶原蛋白
      • 不同材料
    • 基因改造材料
      • 去氧核糖核酸转染载体
      • 基因工程细胞
      • 3D聚合物技术
      • 基因改造技术
      • 纤维母细胞
      • 神经干细胞
      • 基因活化矩阵
    • 药品
      • 低分子
      • 生技药品
  • 全球再生医学市场按产品划分
    • 基于细胞的免疫疗法和细胞治疗产品
    • 组织工程产品
    • 小分子和生技药品
    • 基因治疗产品
  • 全球再生医学市场的应用
    • 肌肉骨骼疾病
    • 创伤护理
    • 肿瘤学
    • 眼科疾病
    • 糖尿病
    • 其他的
  • 按分销管道分類的全球再生医学市场
    • 医院
    • 诊所
    • 其他的

第四章 区域市场趋势及预测分析

  • 全球再生医学市场按地区划分
  • 北美再生医学市场
  • 欧洲再生医学市场
  • 亚太再生医学市场
  • 其他地区再生医学市场

第五章 竞争分析

  • 市场占有率分析
  • 产品系列分析
  • 营运整合
  • 地理范围
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球再生医学市场按材料的成长机会
    • 全球再生医学市场成长机会（按产品）
    • 全球再生医学市场成长机会（按应用）
    • 按分销管道分類的全球再生医学市场成长机会
    • 全球再生医学市场成长机会（按地区）
  • 全球再生医学市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球再生医学市场容量
    • 全球再生医学市场的合併、收购与合资

第七章主要企业概况

  • Kite Pharma
  • Novartis
  • Vericel Corporation
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker Corporation
  • Spark Therapeutics
  • Zimmer Biomet Holdings, Inc.
简介目录

Regenerative Medicine Market Trends and Forecast

The future of the global regenerative medicine market looks promising with opportunities in musculoskeletal disorders, wound care, oncology, ocular disorders, and diabetes. The global regenerative medicine market is expected to reach an estimated $10.2 billion by 2030, and it is forecast to grow at a CAGR of 3.0% from 2024 to 2030. The major drivers for this market are increasing preference of people for personalized medicines, rising investment by governments and private agencies regarding research and development activities, and technological advancements in stem-cell therapies.

Emerging Trends in the Regenerative Medicine Market

Emerging trends, which have a direct impact on the dynamics of the industry, include increasing adoption of stem cell technologies and increasing use of 3D bioprinting technologies in tissue engineering & regenerative medicine.

A total of 94 figures / charts and 87 tables are provided in this more than 184-page report to help in your business decisions. Sample figures with some insights are shown below.

In this market, cell-based immunology & cell therapy is the largest product of regenerative medicine, whereas musculoskeletal disorders is the largest application. Growth in various segments of the regenerative medicine market are given below:

The study includes trends and forecast for the global regenerative medicine market by material, product, application, distribution channel, and region as follows:

By Material [Value ($ Million) shipment analysis for 2018 - 2030]:

  • Synthetic
    • Scaffold
    • Artificial Vascular Graft Materials
    • Hydrogel Materials
  • Biologically Derived Materials
    • Collagen
    • Xenogeneic Materials
  • Genetically Engineered Materials
    • Deoxyribonucleic Acid Transfection Vectors
    • Genetically Manipulated Cells
    • Three-Dimensional Polymer Technology
    • Transgenics
    • Fibroblasts
    • Neural Stem Cells
    • Gene-Activated Matrices
  • Pharmaceuticals
    • Small Molecules
    • Biologics

By Product [Value ($ Million) shipment analysis for 2018 - 2030]:

  • Cell-Based Immunotherapy & Cell Therapy Products
  • Tissue-Engineered Products
  • Small Molecules and Biologics
  • Gene Therapy Products

By Application [Value ($ Million) shipment analysis for 2018 - 2030]:

  • Musculoskeletal Disorders
  • Wound Care
  • Oncology
  • Ocular Disorders
  • Diabetes
  • Other Applications

By Distribution Channel [Value ($ Million) shipment analysis for 2018 - 2030]:

  • Hospitals
  • Clinics
  • Others

By Region [Value ($ Million) shipment analysis for 2018 - 2030]:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • The Rest of the World
    • Brazil

List of Regenerative Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies regenerative medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the regenerative medicine companies profiled in this report include.

  • Kite Pharma
  • Novartis
  • Vericel
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker
  • Spark Therapeutics
  • Zimmer Biomet

Regenerative Medicine Market Insights

  • Lucintel forecasts that cell-based immunology and cell therapy products will remain the largest segment over the forecast period due to increasing government support in research and development activities related to cell therapy products and establishment of the Cures Act by FDA for streamlining the approval of regenerative medicine.
  • Within this market, musculoskeletal disorders will remain the largest segment by application over the forecast period due to increasing orthopedic diseases and rising geriatric population.
  • North America will remain the largest region over the forecast period due to presence of advanced technologies and a large number of research institutes involved in the development of novel therapeutics.

Features of the Regenerative Medicine Market

  • Market Size Estimates: Regenerative medicine market size estimation in terms of value ($M).
  • Trend and Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments and regions.
  • Segmentation Analysis: Regenerative medicine market size by various segments, such as material, product, application, and distribution channel.
  • Regional Analysis: Regenerative medicine market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different material, product, application, distribution channel, and regions for regenerative medicine market.
  • Strategic Analysis: This includes M&A and competitive landscape for the regenerative medicine .
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the regenerative medicine market size?

Answer:The global regenerative medicine market is expected to reach an estimated $10.2 billion by 2030.

Q2. What is the growth forecast for regenerative medicine market?

Answer:The regenerative medicine market is expected to grow at a CAGR of 3.0% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the regenerative medicine market?

Answer: The major drivers for this market are increasing preference of people for personalized medicines, rising investment by governments and private agencies regarding research and development activities, and technological advancements in stem-cell therapies.

Q4. What are the major applications or end use industries for regenerative medicine?

Answer:Hospital and clinic are the major end uses for regenerative medicine

Q5. What are the emerging trends in regenerative medicine market?

Answer:Emerging trends, which have a direct impact on the dynamics of the industry, include increasing adoption of stem cell technologies and increasing use of 3D bioprinting technologies in tissue engineering & regenerative medicine.

Q6. Who are the key regenerative medicine companies?

Answer:Some of the key regenerative medicine companies are as follows:

  • Kite Pharma
  • Novartis
  • Vericel
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker
  • Spark Therapeutics
  • Zimmer Biomet

Q7.Which regenerative medicine raw material segment will be the largest in future?

Answer: Lucintel forecasts that cell-based immunology and cell therapy products will remain the largest segment over the forecast period due to increasing government support in research and development activities related to cell therapy products and establishment of the Cures Act by FDA for streamlining the approval of regenerative medicine.

Q8: In regenerative medicine market, which region is expected to be the largest in next 5 years?

Answer:North America will remain the largest region in next 5 years.

Q9. Do we receive customization in this report?

Answer:Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1 What are some of the most promising potential, high-growth opportunities for the global regenerative medicine market by material (synthetic (scaffold, artificial vascular graft materials, and hydrogel materials), biologically derived materials (collagen and xenogeneic materials), genetically engineered materials (deoxyribonucleic acid transfection vectors, genetically manipulated cells, three-dimensional polymer technology, transgenics, fibroblasts, neural stem cells, and gene-activated matrices), and pharmaceuticals (small molecules and biologics)), product (cell-based immunotherapy & cell therapy products, tissue-engineered products, small molecules and biologics, and gene therapy products), application (musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and other applications), distribution channel (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
  • Q. 2 Which segments will grow at a faster pace and why?
  • Q.3 Which region will grow at a faster pace and why?
  • Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the market?
  • Q.5 What are the business risks and threats to the market?
  • Q.6 What are the emerging trends in this market and the reasons behind them?
  • Q.7 What are some changing demands of customers in the market?
  • Q.8 What are the new developments in the market? Which companies are leading these developments?
  • Q.9 Who are the major players in this market? What strategic initiatives are being implemented by key players for business growth?
  • Q.10 What are some of the competitive products and processes in this market, and how big of a threat do they pose for loss of market share via material or product substitution?
  • Q.11 What M & A activities did take place in the last five years in this market?

Table of Contents

2. Market Background and Classifications

  • 2.1 Introduction, Background, and Classifications
  • 2.2 Supply Chain
  • 2.3 Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1 Macroeconomic Trends and Forecast
  • 3.2 Global Regenerative Medicine Market Trends and Forecast
  • 3.3 Global Regenerative Medicine Market by Material
    • 3.3.1 Synthetic
      • 3.3.1.1 Scaffold
      • 3.3.1.2 Artificial Vascular Graft Materials
      • 3.3.1.3 Hydrogel Materials
    • 3.3.2 Biologically Derived Materials
      • 3.3.2.1 Collagen
      • 3.3.2.2 Xenogeneic Materials
    • 3.3.3 Genetically Engineered Materials
      • 3.3.3.1 Deoxyribonucleic Acid Transfection Vectors
      • 3.3.3.2 Genetically Manipulated Cells
      • 3.3.3.3 Three-dimensional Polymer Technology
      • 3.3.3.4 Transgenics
      • 3.3.3.5 Fibroblasts
      • 3.3.3.6 Neural Stem Cells
      • 3.3.3.7 Gene-activated Matrices
    • 3.3.4 Pharmaceuticals
      • 3.3.4.1 Small Molecules
      • 3.3.4.2 Biologics
  • 3.4 Global Regenerative Medicine Market by Product
    • 3.4.1 Cell-Based Immunotherapy & Cell Therapy Products
    • 3.4.2 Tissue-Engineered Products
    • 3.4.3 Small Molecules And Biologics
    • 3.4.4 Gene Therapy Products
  • 3.5 Global Regenerative Medicine Market by Application
    • 3.5.1 Musculoskeletal Disorders
    • 3.5.2 Wound Care
    • 3.5.3 Oncology
    • 3.5.4 Ocular Disorders
    • 3.5.5 Diabetes
    • 3.5.6 Other Applications
  • 3.6 Global Regenerative Medicine Market by Distribution Channel
    • 3.6.1 Hospitals
    • 3.6.2 Clinic
    • 3.6.3 Others

4. Market Trends and Forecast Analysis by Region

  • 4.1 Global Regenerative Medicine Market by Region
  • 4.2 North American Regenerative Medicine Market
    • 4.2.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
    • 4.2.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
    • 4.2.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
    • 4.2.4 Market by Distribution Channel: Hospitals, Clinics, and Others
    • 4.2.5 The United States Regenerative Medicine Market
    • 4.2.6 The Canadian Regenerative Medicine Market
    • 4.2.7 The Mexican Regenerative Medicine Market
  • 4.3 European Regenerative Medicine Market
    • 4.3.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
    • 4.3.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
    • 4.3.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
    • 4.3.4 Market by Distribution Channel: Hospitals, Clinics, and Others
    • 4.3.5 The Regenerative Medicine Market of the United Kingdom
    • 4.3.6 The German Regenerative Medicine Market
    • 4.3.7 The French Regenerative Medicine Market
  • 4.4 APAC Regenerative Medicine Market
    • 4.4.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
    • 4.4.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
    • 4.4.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
    • 4.4.4 Market by Distribution Channel: Hospitals, Clinics, and Others
    • 4.4.5 The Chinese Regenerative Medicine Market
    • 4.4.6 The Indian Regenerative Medicine Market
    • 4.4.7 The Japanese Regenerative Medicine Market
  • 4.5 ROW Regenerative Medicine Market
    • 4.5.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
    • 4.5.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
    • 4.5.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
    • 4.5.4 Market by Distribution Channel: Hospitals, Clinics, and Others
    • 4.5.5 Brazilian Regenerative Medicine Market

5. Competitor Analysis

  • 5.1 Market Share Analysis
  • 5.2 Product Portfolio Analysis
  • 5.3 Operational Integration
  • 5.4 Geographical Reach
  • 5.5 Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1 Growth Opportunity Analysis
    • 6.1.1 Growth Opportunities for the Global Regenerative Medicine Market by Material
    • 6.1.2 Growth Opportunities for the Global Regenerative Medicine Market by Product
    • 6.1.3 Growth Opportunities for the Global Regenerative Medicine Market by Application
    • 6.1.4 Growth Opportunities for the Global Regenerative Medicine Market by Distribution Channel
    • 6.1.5 Growth Opportunities for the Global Regenerative Medicine Market by Region
  • 6.2 Emerging Trends in the Global Regenerative Medicine Market
  • 6.3 Strategic Analysis
    • 6.3.1 New Product Development
    • 6.3.2 Capacity Expansion of the Global Regenerative Medicine Market
    • 6.3.3 Mergers, Acquisitions, and Joint Ventures in the Global Regenerative Medicine Market

7. Company Profiles of Leading Players

  • 7.1 Kite Pharma
  • 7.2 Novartis
  • 7.3 Vericel Corporation
  • 7.4 Integra LifeSciences
  • 7.5 Wright Medical
  • 7.6 MiMedx
  • 7.7 Osiris Therapeutics
  • 7.8 Stryker Corporation
  • 7.9 Spark Therapeutics
  • 7.10 Zimmer Biomet Holdings, Inc.